As of May 25
| +0.16 / +2.17%|
The 4 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +32.80% increase from the last price of 7.53.
The current consensus among 4 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.